• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX INC. VISIFLEX; BIFURCATED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX INC. VISIFLEX; BIFURCATED Back to Search Results
Model Number 25-16-140BL - US SUREPASS
Device Problems Failure To Adhere Or Bond (1031); Collapse (1099); Hole In Material (1293); Leak/Splash (1354); Unintended Movement (3026)
Patient Problems Failure of Implant (1924); No Code Available (3191)
Event Date 05/12/2016
Event Type  Injury  
Manufacturer Narrative
The devices involved in the event will not be returned for evaluation, they remain implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Devices remain implanted in the patient.
 
Event Description
The patient was initially implanted with a bifurcated stent, a suprarenal aortic extension and a limb stent on (b)(6) 2008.On (b)(6) 2016 a follow up computed tomography (ct) scan showed an unknown endoleak.The physician suspects a type 3b endoleak and slight aneurysm sac growth.The physician initially was not going to complete an endovascular repair due to the fragile nature of the patient.On (b)(6) 2016 the physician elected to reline the initial bifurcated stent and implanted an additional bifurcated stent to seal the endoleak.The patient is stable.
 
Manufacturer Narrative
At the completion of the investigation, the clinical evaluation was able to confirm the reported type 3b endoleak and aneurysm sac expansion.Additionally there was evidence to reasonably support the following observations; at 52 months post implant a partial stent collapse, progressive stent collapse and stent movement of the infrarenal cuff.The clinical assessment was based on no medical records and suboptimal patient images.The manufacturing evaluation did not reveal any issues or deviations that would explain the reported event.The manufacturing lot evaluation confirmed all devices met specifications prior to release.The root cause of the reported event is unknown, there is not enough information to determine the root cause of the reported event.The event devices remain implanted in the patient and were not returned for further evaluation.The clinical evaluation was unable to identify any potential contributing factors to the reported event due to the limited patient information available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VISIFLEX
Type of Device
BIFURCATED
Manufacturer (Section D)
ENDOLOGIX INC.
2 musick
irvine CA 92618
Manufacturer Contact
tahereh sedighi
2 musick
irvine, CA 92618
9495984671
MDR Report Key5992507
MDR Text Key56094801
Report Number2031527-2016-00464
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/01/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2011
Device Model Number25-16-140BL - US SUREPASS
Device Lot NumberW08-1093-015
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/01/2016
Initial Date FDA Received10/01/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received12/15/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/18/2008
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
LIMB EXTENSION- W08-0765-007; SUPRARENAL AORTA UNI-ILIAC- W08-0248-004
Patient Outcome(s) Required Intervention;
Patient Age66 YR
-
-